CVRx Reports Fourth Quarter and Full Year 2023 Financial and Operating Results

January 25, 2024

https://www.globenewswire.com/news-release/2024/01/25/2817386/0/en/CVRx-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-and-Operating-Results.html

MINNEAPOLIS, Jan. 25, 2024 (GLOBE NEWSWIRE) — CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced its financial and operating results for the fourth quarter and full year of 2023, and affirmed its 2024 business outlook.

Read more at globenewswire.com

Related news for (CVRX)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.